---
title: "Incyte President, Global Head of R&D Pablo J. Cagnoni sells 10,801 shares for $1.36 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296537435.md"
description: "Incyte Corporation President and Global Head of R&D, Pablo J. Cagnoni, sold 10,801 common shares on August 19, 2026, at a price of $125.56 per share, totaling approximately $1.36 million. Following this transaction, his directly held stake in the company stands at 183,200 shares. The information was published via EDGAR by Incyte Corporation."
datetime: "2026-08-20T21:16:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296537435.md)
  - [en](https://longbridge.com/en/news/296537435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296537435.md)
generator: "portal-rs"
---

# Incyte President, Global Head of R&D Pablo J. Cagnoni sells 10,801 shares for $1.36 million

-   Pablo J. Cagnoni, President, Global Head of R&D, sold 10,801 Incyte common shares on Aug. 19, 2026. \* Sale price USD 125.56 per share. \* Directly held stake stood at 183,200 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001205703-26-000028), on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [INCY.US](https://longbridge.com/en/quote/INCY.US.md)

## Related News & Research

- [Incyte to present at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/297648705.md)
- [What Does Incyte (INCY) Medicare Deal Mean For Future Drug Pricing Risk?](https://longbridge.com/en/news/298140297.md)
- [PACS Group CEO and Chairman Jason Hulse sells USD 2.91 million common shares](https://longbridge.com/en/news/297970499.md)
- [Septerna files initial beneficial ownership statement for Chief Medical Officer Rajiv Patni](https://longbridge.com/en/news/297966030.md)
- [TELA Bio announces special shareholder meeting](https://longbridge.com/en/news/298071346.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**